Hereditary haemochromatosis mutation frequencies in the general population

Journal of Medical Screening

Volumn 5, Issue 1, 1998, Pages 34-36

  Bradley, Linda A ^a   Johnson, Dorene D ^a   Palomaki, Glenn E ^a   Haddow, James E ^a   Robertson, Nancy H ^b   Ferrie, Richard M ^b  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Haemochromatosis; HFE mutations; Iron storage; Population screening

Indexed keywords

ARTICLE; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; GENETIC SCREENING; HEMOCHROMATOSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS;

EID: 0031777070     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.5.1.34     Document Type: Article

References (16)

1. Edwards CQ, Kushner JP. Screening for hemochromatosis. N Engl J Med 1993;328:1616-20.
2. Haddow JE, Ledue TB. Preventing manifestations of hereditary haemochromatosis through population based screening. J Med Screen 1994;1:16-21.
3. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nature Genet 1996;13:399-408.
4. Witte DL, Crosby WH, Edwards CQ, et al. Practice Guideline Development Task Force of the College of American Pathologists: Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
5. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nature Genet 1996;14:249-51.
6. Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nature Genet 1996;14:251-2.
7. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Mol Dis 1996;22: 187-94.
8. Borot N, Roth MP, Malroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997;45:320-4.
9. Roberts AG, Whatley SD, Morgan RR, et al. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria tarda. Lancet 1997;349:321-3.
10. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.
11. Doherty RA, Palomaki GE, Kloza EM, et al. Couple-based screening for cystic fibrosis in primary care settings. Prenat Diagn 1996;16:397-104.
12. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl Acids Res 1989;17:2503-16.
13. Ferrie RM, Schwarz MJ, Robertson NH, et al. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene. Am J Hum Genet 1992;51:251-62.
14. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen 1996;3: 171-7.
15. Bradley LA, Haddow JE, Palomaki GE. Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen 1996;3:178-84.
16. Waldron T. CDC recommends routine screening for 'iron overload'. Medical Tribune 1997;38:1.